Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind, Polysomnographic, Two-Way Crossover Study To Compere The Efficacy Of Gastric Retentive Zaleplon (Zaleplon AP) To Placebo In Subjects With Insomnia Characterized By Both Difficulty In Falling Asleep And Staying Asleep

NCT01277107 is registered in ClinicalTrials.gov with Intec Pharma Ltd. as lead sponsor.

NCT NCT01277107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01277107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind, Polysomnographic, Two-Way Crossover Study To Compere The Efficacy Of Gastric Retentive Zaleplon (Zaleplon AP) To Placebo In Subjects With Insomnia Characterized By Both Difficulty In Falling Asleep And Staying Asleep
Lead sponsor
Intec Pharma Ltd.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2011
Completion date
September 30, 2011
Enrollment
83 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia